RANIBIZUMAB

RANIBIZUMAB was reported 26488 times

RANIBIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONJUNCTIVAL RETRACTION 12 0.7500
1 FOVEAL REFLEX ABNORMAL 11 0.6471
2 POLYPOIDAL CHOROIDAL VASCULOPATHY 199 0.6419
3 RETINAL PIGMENT EPITHELIAL TEAR 322 0.4640
4 CONJUNCTIVAL BLEB 25 0.4630
5 DIABETIC RETINAL OEDEMA 229 0.4508
6 SUBRETINAL FIBROSIS 83 0.4256
7 CHOROIDAL NEOVASCULARISATION 359 0.4184
8 MACULAR SCAR 73 0.3763
9 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 312 0.3506
10 RETINAL PALLOR 7 0.3500
11 RETINAL SCAR 154 0.3341
12 RETINAL CYST 54 0.3253
13 SUBRETINAL FLUID 338 0.3092
14 IRIS INJURY 10 0.2941
15 AGE-RELATED MACULAR DEGENERATION 445 0.2930
16 CONJUNCTIVAL EROSION 35 0.2893
17 ANGIOGRAM RETINA ABNORMAL 8 0.2667
18 SUBRETINAL HAEMATOMA 12 0.2667
19 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 13 0.2500
20 RETINAL FIBROSIS 18 0.2500
21 EXUDATIVE RETINOPATHY 14 0.2456
22 CATARACT TRAUMATIC 10 0.2326
23 RETINAL NEOVASCULARISATION 58 0.2302
24 MACULAR CYST 17 0.2024
25 RETINAL OEDEMA 372 0.1944
26 RETINOPATHY OF PREMATURITY 107 0.1931
27 PSEUDOENDOPHTHALMITIS 19 0.1919
28 RETINAL DEPIGMENTATION 58 0.1895
29 RETINAL ANEURYSM 35 0.1750
30 HYALOSIS ASTEROID 7 0.1707
31 RETINAL DRUSEN 28 0.1707
32 VITREOUS HAEMORRHAGE 458 0.1656
33 CATARACT NUCLEAR 105 0.1574
34 RETINAL EXUDATES 147 0.1571
35 MACULAR PIGMENTATION 13 0.1548
36 VITREOUS ADHESIONS 17 0.1478
37 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 198 0.1416
38 CHOROIDAL HAEMORRHAGE 25 0.1295
39 MACULAR FIBROSIS 86 0.1268
40 POSTERIOR CAPSULE RUPTURE 10 0.1266
41 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 22 0.1243
42 ENDOPHTHALMITIS 739 0.1231
43 POSTERIOR CAPSULE OPACIFICATION 42 0.1224
44 INCREASED INSULIN REQUIREMENT 29 0.1224
45 RETINAL VASCULAR DISORDER 71 0.1214
46 IRIS NEOVASCULARISATION 15 0.1200
47 MACULAR THICKENING 10 0.1190
48 EYE INFECTION INTRAOCULAR 9 0.1154
49 PSEUDOPHAKIA 10 0.1149
50 RETINAL HAEMORRHAGE 801 0.1123
51 METAMORPHOPSIA 204 0.1106
52 CHORIORETINAL SCAR 9 0.1084
53 RETINAL ISCHAEMIA 64 0.1047
54 VITREOUS HAZE 16 0.1046
55 MACULAR OEDEMA 584 0.1041
56 CUTIS LAXA 28 0.1029
57 RETINOSCHISIS 14 0.1014
58 CATARACT CORTICAL 15 0.1007
59 CHARLES BONNET SYNDROME 12 0.1000
60 VITREOUS OPACITIES 84 0.0994
61 ANTERIOR CHAMBER FLARE 23 0.0987
62 CORNEAL STRIAE 7 0.0986
63 RETINOPATHY PROLIFERATIVE 19 0.0974
64 SCOTOMA 71 0.0959
65 NEOVASCULARISATION 25 0.0951
66 MACULAR HOLE 126 0.0938
67 CYSTOID MACULAR OEDEMA 176 0.0933
68 VITREOUS DISORDER 45 0.0932
69 CHORIORETINAL ATROPHY 19 0.0918
70 TRACTIONAL RETINAL DETACHMENT 10 0.0901
71 NON-INFECTIOUS ENDOPHTHALMITIS 76 0.0895
72 ANTERIOR CHAMBER INFLAMMATION 53 0.0891
73 VISUAL ACUITY REDUCED 2893 0.0870
74 VITREOUS DEGENERATION 14 0.0854
75 OCULAR ISCHAEMIC SYNDROME 7 0.0824
76 EYE HAEMORRHAGE 1050 0.0786
77 CORNEAL EXFOLIATION 8 0.0784
78 HYPHAEMA 40 0.0766
79 VITRITIS 139 0.0750
80 RETINAL DEGENERATION 97 0.0746
81 TACHYPHYLAXIS 26 0.0745
82 ANTERIOR CHAMBER CELL 53 0.0742
83 LENS DISORDER 21 0.0729
84 EPIRETINAL MEMBRANE 20 0.0719
85 OCULAR HYPERTENSION 139 0.0715
86 RETINAL VEIN OCCLUSION 203 0.0706
87 DRY AGE-RELATED MACULAR DEGENERATION 75 0.0676
88 FUNDOSCOPY ABNORMAL 7 0.0673
89 PINGUECULA 7 0.0660
90 HYPOPYON 54 0.0652
91 LENTICULAR OPACITIES 28 0.0641
92 VITREOUS DETACHMENT 138 0.0636
93 VITREOUS FLOATERS 622 0.0632
94 CORNEAL ENDOTHELIITIS 6 0.0625
95 CATARACT SUBCAPSULAR 38 0.0623
96 RHEGMATOGENOUS RETINAL DETACHMENT 13 0.0622
97 HYPOTONY OF EYE 26 0.0619
98 RETINAL THICKENING 102 0.0611
99 NORMAL TENSION GLAUCOMA 7 0.0603
100 INTRAOCULAR MELANOMA 8 0.0602
101 VITREAL CELLS 12 0.0594
102 VISUAL ACUITY REDUCED TRANSIENTLY 18 0.0584
103 CENTRAL VISION LOSS 13 0.0583
104 MACULAR DETACHMENT 14 0.0579
105 RETINAL DISORDER 149 0.0572
106 RETINAL TEAR 134 0.0543
107 SUDDEN VISUAL LOSS 15 0.0538
108 ANTERIOR CHAMBER DISORDER 12 0.0522
109 VITRECTOMY 31 0.0520
110 RETINAL VASCULITIS 60 0.0504
111 BACTERIAL ENDOPHTHALMITIS 13 0.0489
112 RETINAL ARTERY THROMBOSIS 11 0.0487
113 KERATIC PRECIPITATES 23 0.0484
114 ATROPHY OF GLOBE 6 0.0469
115 GLARE 24 0.0468
116 VISUAL ACUITY TESTS ABNORMAL 26 0.0468
117 OCULAR VASCULITIS 8 0.0462
118 SUTURE RUPTURE 32 0.0462
119 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 56 0.0450
120 DEPOSIT EYE 12 0.0448
121 CORNEAL EROSION 24 0.0445
122 PANOPHTHALMITIS 8 0.0437
123 CORNEAL DECOMPENSATION 7 0.0435
124 OCULAR VASCULAR DISORDER 35 0.0424
125 RETINAL ARTERY OCCLUSION 104 0.0411
126 CHORIORETINAL DISORDER 8 0.0406
127 SEROUS RETINAL DETACHMENT 34 0.0406
128 INTRAOCULAR LENS IMPLANT 20 0.0404
129 RETINAL OCCLUSIVE VASCULITIS 9 0.0402
130 RETINAL VASCULAR THROMBOSIS 21 0.0400
131 INTRAOCULAR PRESSURE DECREASED 21 0.0398
132 RETINAL PIGMENT EPITHELIOPATHY 17 0.0394
133 CORNEAL LESION 12 0.0390
134 RETINAL DETACHMENT 354 0.0385
135 IIIRD NERVE PARESIS 7 0.0385
136 RETINAL ARTERY EMBOLISM 8 0.0381
137 OPTIC DISC DISORDER 8 0.0381
138 EYE INFECTION STAPHYLOCOCCAL 11 0.0381
139 EYE OEDEMA 92 0.0375
140 OPEN ANGLE GLAUCOMA 23 0.0375
141 RETINAL INFARCTION 9 0.0366
142 XEROPHTHALMIA 21 0.0358
143 MACULOPATHY 126 0.0355
144 CORNEAL ABRASION 48 0.0350
145 RETINAL DEPOSITS 7 0.0345
146 COLOUR BLINDNESS ACQUIRED 12 0.0331
147 BLINDNESS UNILATERAL 466 0.0330
148 INTRAOCULAR PRESSURE INCREASED 416 0.0325
149 CHOROIDAL DETACHMENT 18 0.0324
150 DIABETIC RETINOPATHY 110 0.0324
151 IRIDOCYCLITIS 101 0.0319
152 CONJUNCTIVAL DISORDER 12 0.0315
153 OPTIC DISC HAEMORRHAGE 7 0.0306
154 RETINAL INJURY 23 0.0298
155 PHOTOPSIA 186 0.0294
156 MACULAR DEGENERATION 351 0.0294
157 FOREIGN BODY IN EYE 28 0.0292
158 CORNEAL SCAR 14 0.0278
159 RETINOPATHY HYPERTENSIVE 8 0.0264
160 EYE INFLAMMATION 249 0.0261
161 BLINDNESS 1051 0.0258
162 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 20 0.0233
163 INTRAOCULAR PRESSURE TEST ABNORMAL 16 0.0227
164 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 7 0.0226
165 CHOROIDAL EFFUSION 18 0.0224
166 RETINAL VASCULAR OCCLUSION 16 0.0216
167 CONJUNCTIVAL HAEMORRHAGE 82 0.0214
168 CORNEAL OEDEMA 47 0.0210
169 FOREIGN BODY SENSATION IN EYES 132 0.0207
170 EYE INJURY 61 0.0201
171 EYE INFECTION BACTERIAL 11 0.0197
172 IRIS ADHESIONS 10 0.0195
173 AMBLYOPIA 11 0.0186
174 PUNCTATE KERATITIS 17 0.0185
175 COLOUR BLINDNESS 17 0.0185
176 BLINDNESS TRANSIENT 135 0.0183
177 EYE DISCHARGE 189 0.0182
178 EYELID INFECTION 8 0.0181
179 PUPILLARY DISORDER 11 0.0181
180 EYE INFECTION 203 0.0180
181 CORNEAL DISORDER 38 0.0173
182 TEMPORAL ARTERITIS 16 0.0173
183 EYE PAIN 962 0.0170
184 VISUAL FIELD DEFECT 123 0.0170
185 CORNEAL DYSTROPHY 7 0.0167
186 CORNEAL OPACITY 22 0.0161
187 IRITIS 48 0.0158
188 CHORIORETINITIS 10 0.0155
189 CORNEAL EPITHELIUM DEFECT 9 0.0155
190 MEIBOMIAN GLAND DYSFUNCTION 7 0.0155
191 STAPHYLOCOCCUS TEST POSITIVE 31 0.0147
192 GLAUCOMA 283 0.0147
193 TOXIC ANTERIOR SEGMENT SYNDROME 16 0.0147
194 NECROTISING RETINITIS 9 0.0141
195 INTERCEPTED MEDICATION ERROR 65 0.0140
196 RETINAL PIGMENTATION 11 0.0140
197 BRAIN STEM INFARCTION 14 0.0137
198 UVEITIS 184 0.0136
199 VISUAL IMPAIRMENT 1677 0.0135
200 INJURY CORNEAL 7 0.0135
201 DIABETIC FOOT 41 0.0134
202 AMAUROSIS 11 0.0131
203 OCULAR DISCOMFORT 145 0.0129
204 INTERCEPTED PRODUCT STORAGE ERROR 46 0.0129
205 EYE DISORDER 423 0.0129
206 ABNORMAL SENSATION IN EYE 54 0.0125
207 CEREBELLAR INFARCTION 21 0.0124
208 HEMIANOPIA HOMONYMOUS 9 0.0123
209 OPTIC ATROPHY 20 0.0123
210 MYOPIA 29 0.0122
211 CONJUNCTIVAL HYPERAEMIA 42 0.0118
212 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 24 0.0118
213 BRONCHOPNEUMONIA 40 0.0117
214 CATARACT 692 0.0116
215 RETINAL VEIN THROMBOSIS 8 0.0115
216 VASOCONSTRICTION 10 0.0114
217 AMAUROSIS FUGAX 12 0.0111
218 CEREBRAL INFARCTION 271 0.0111
219 VASCULAR RUPTURE 17 0.0110
220 CONJUNCTIVAL OEDEMA 11 0.0107
221 NIGHT BLINDNESS 17 0.0106
222 CHORIORETINOPATHY 15 0.0105
223 EYE CONTUSION 22 0.0104
224 CENTRAL SEROUS CHORIORETINOPATHY 7 0.0102
225 CONCOMITANT DISEASE PROGRESSION 20 0.0102
226 ANGLE CLOSURE GLAUCOMA 26 0.0102
227 SUPERFICIAL INJURY OF EYE 11 0.0101
228 CRANIAL NERVE DISORDER 7 0.0100
229 GIANT CELL ARTERITIS 8 0.0096
230 LACRIMATION INCREASED 290 0.0096
231 OCULAR HYPERAEMIA 453 0.0095
232 ULCERATIVE KERATITIS 26 0.0095
233 BLEPHARITIS 38 0.0095
234 CHALAZION 6 0.0094
235 VASCULAR DEMENTIA 8 0.0091
236 ASTHENOPIA 50 0.0091
237 TRANSIENT ISCHAEMIC ATTACK 303 0.0090
238 BRONCHIAL CARCINOMA 7 0.0089
239 PUPILLARY REFLEX IMPAIRED 16 0.0086
240 OPTIC NERVE INJURY 10 0.0086
241 ALTERED VISUAL DEPTH PERCEPTION 7 0.0085
242 HYPERMETROPIA 8 0.0084
243 READING DISORDER 19 0.0083
244 LEFT VENTRICULAR FAILURE 28 0.0081
245 OPTIC NERVE DISORDER 13 0.0081
246 THALAMUS HAEMORRHAGE 7 0.0080
247 ASTIGMATISM 12 0.0079
248 MYOCARDIAL ISCHAEMIA 88 0.0077
249 KERATITIS 23 0.0076
250 VISION BLURRED 1036 0.0075
251 RETINITIS 13 0.0075
252 PHOTOPHOBIA 140 0.0074
253 CATARACT OPERATION 44 0.0074
254 CEREBROVASCULAR ACCIDENT 1239 0.0073
255 VISUAL DISTURBANCE 41 0.0071
256 HYPERTROPHIC CARDIOMYOPATHY 11 0.0071
257 DRY THROAT 71 0.0070
258 POLYMYALGIA RHEUMATICA 22 0.0069
259 AORTIC STENOSIS 24 0.0069
260 EYE PRURITUS 229 0.0068
261 LACUNAR INFARCTION 16 0.0067
262 CONCOMITANT DISEASE AGGRAVATED 40 0.0065
263 EYE ALLERGY 10 0.0065
264 ANEURYSM 32 0.0064
265 ISCHAEMIC STROKE 112 0.0063
266 HAEMORRHAGIC STROKE 49 0.0063
267 VENOUS OCCLUSION 11 0.0060
268 DEAFNESS 154 0.0059
269 NO ADVERSE EVENT 1061 0.0059
270 CAROTID ARTERIOSCLEROSIS 6 0.0058
271 EYE IRRITATION 333 0.0058
272 CEREBRAL ISCHAEMIA 29 0.0056
273 SUDDEN HEARING LOSS 11 0.0054
274 EYELID PAIN 11 0.0054
275 EYE SWELLING 196 0.0053
276 FEMORAL NECK FRACTURE 27 0.0053
277 HEPATIC NEOPLASM MALIGNANT 11 0.0052
278 INFARCTION 35 0.0051
279 PHARYNGEAL OEDEMA 78 0.0051
280 DIABETIC NEPHROPATHY 11 0.0050
281 CEREBROVASCULAR DISORDER 15 0.0050
282 CEREBRAL ARTERY EMBOLISM 6 0.0049
283 VIITH NERVE PARALYSIS 17 0.0049
284 PERIPHERAL ISCHAEMIA 20 0.0049
285 VASCULAR INJURY 7 0.0048
286 CONJUNCTIVITIS ALLERGIC 7 0.0047
287 OPTIC NEUROPATHY 10 0.0047
288 POOR PERIPHERAL CIRCULATION 20 0.0047
289 HEARING IMPAIRED 28 0.0047
290 FIBROSIS 14 0.0045
291 OPHTHALMIC HERPES ZOSTER 8 0.0044
292 DEATH 3804 0.0044
293 OPTIC ISCHAEMIC NEUROPATHY 17 0.0044
294 SKULL FRACTURE 7 0.0043
295 CAROTID ARTERY STENOSIS 15 0.0043
296 RETINOPATHY 16 0.0043
297 HYPERTENSIVE HEART DISEASE 8 0.0043
298 EMBOLIC STROKE 15 0.0043
299 DISEASE RECURRENCE 198 0.0042
300 DRY EYE 207 0.0041
301 HYPERTENSIVE CRISIS 46 0.0041
302 CARDIAC FIBRILLATION 6 0.0041
303 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 8 0.0040
304 ANGINA UNSTABLE 26 0.0040
305 VERTIGO POSITIONAL 7 0.0040
306 CONJUNCTIVITIS 74 0.0040
307 MYOCARDIAL INFARCTION 690 0.0040
308 FIBRIN D DIMER INCREASED 14 0.0039
309 HORDEOLUM 17 0.0039
310 ANGINA PECTORIS 112 0.0039
311 EYELID MARGIN CRUSTING 11 0.0038
312 STRABISMUS 11 0.0037
313 SLOW SPEECH 9 0.0037
314 ISCHAEMIA 17 0.0037
315 NO THERAPEUTIC RESPONSE 45 0.0037
316 BRONCHITIS CHRONIC 9 0.0037
317 DISEASE PROGRESSION 426 0.0036
318 EOSINOPHIL COUNT INCREASED 30 0.0036
319 CORONARY ARTERY STENOSIS 18 0.0036
320 ACUTE CORONARY SYNDROME 29 0.0035
321 METASTATIC NEOPLASM 15 0.0035
322 EYELID DISORDER 8 0.0035
323 PELVIC FRACTURE 27 0.0035
324 ACUTE MYOCARDIAL INFARCTION 101 0.0034
325 MULTIPLE USE OF SINGLE-USE PRODUCT 19 0.0034
326 HEMIPLEGIA 28 0.0034
327 VASCULAR OCCLUSION 7 0.0033
328 EYE OPERATION 15 0.0033
329 FACIAL PALSY 7 0.0032
330 EYELIDS PRURITUS 10 0.0032
331 TACHYARRHYTHMIA 8 0.0032
332 HIP FRACTURE 102 0.0032
333 DIABETIC COMPLICATION 8 0.0031
334 EYELID OEDEMA 36 0.0031
335 ATROPHY 6 0.0031
336 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
337 EYELID PTOSIS 31 0.0030
338 ANGIOPATHY 17 0.0030
339 AORTIC ANEURYSM 23 0.0030
340 CAROTID ARTERY OCCLUSION 11 0.0030
341 ARTERIAL OCCLUSIVE DISEASE 23 0.0029
342 SUBDURAL HAEMORRHAGE 8 0.0029
343 VASCULITIS 34 0.0029
344 HYPOACUSIS 125 0.0029
345 UPPER LIMB FRACTURE 57 0.0029
346 PRODUCT CONTAMINATION 10 0.0028
347 SCAR 48 0.0028
348 DEMENTIA 78 0.0028
349 LUNG CANCER METASTATIC 8 0.0028
350 CIRCULATORY COLLAPSE 47 0.0028
351 RENAL FAILURE CHRONIC 21 0.0027
352 AORTIC ARTERIOSCLEROSIS 7 0.0027
353 LIPOMA 7 0.0027
354 ADENOCARCINOMA 6 0.0027
355 INTENTIONAL PRODUCT USE ISSUE 234 0.0027
356 ARTERIOSCLEROSIS 25 0.0027
357 NASAL DISORDER 7 0.0026
358 THROAT TIGHTNESS 71 0.0026
359 SENSATION OF FOREIGN BODY 22 0.0026
360 CERVICAL VERTEBRAL FRACTURE 9 0.0026
361 ERYTHEMA OF EYELID 14 0.0026
362 APHONIA 36 0.0026
363 THROMBOPHLEBITIS 9 0.0026
364 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
365 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 182 0.0026
366 SWELLING OF EYELID 16 0.0025
367 LEUKAEMIA 24 0.0025
368 EMBOLISM 21 0.0025
369 HAEMORRHAGE 263 0.0025
370 CEREBRAL THROMBOSIS 7 0.0025
371 INGUINAL HERNIA 15 0.0025
372 CARDIAC VALVE DISEASE 14 0.0024
373 VASCULAR GRAFT 7 0.0024
374 PROSTATE CANCER METASTATIC 8 0.0024
375 DRUG RESISTANCE 61 0.0024
376 FULL BLOOD COUNT ABNORMAL 25 0.0024
377 PHOTOSENSITIVITY REACTION 39 0.0024
378 PROCEDURAL COMPLICATION 18 0.0023
379 OCCUPATIONAL EXPOSURE TO PRODUCT 15 0.0023
380 POLYP 15 0.0023
381 RECTAL CANCER 7 0.0023
382 CEREBRAL HAEMORRHAGE 80 0.0022
383 CARDIOVASCULAR DISORDER 56 0.0022
384 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
385 ERYSIPELAS 11 0.0022
386 HEMIPARESIS 37 0.0022
387 ATRIAL FIBRILLATION 210 0.0022
388 DYSGRAPHIA 14 0.0021
389 HAND FRACTURE 15 0.0021
390 THERAPEUTIC PRODUCT INEFFECTIVE 8 0.0021
391 LOCALISED INFECTION 50 0.0021
392 SUBARACHNOID HAEMORRHAGE 21 0.0021
393 EYE MOVEMENT DISORDER 14 0.0020
394 COLON CANCER 30 0.0020
395 DIPLOPIA 52 0.0020
396 OFF LABEL USE 1747 0.0020
397 GANGRENE 12 0.0020
398 THROMBOTIC MICROANGIOPATHY 19 0.0019
399 CORONARY ARTERY DISEASE 59 0.0019
400 FACIAL BONES FRACTURE 7 0.0019
401 LEG AMPUTATION 8 0.0019
402 ACCIDENT 23 0.0019
403 DIABETES MELLITUS 145 0.0019
404 HALLUCINATION, VISUAL 40 0.0019
405 SUBDURAL HAEMATOMA 27 0.0019
406 AORTIC VALVE INCOMPETENCE 8 0.0019
407 GASTROINTESTINAL CARCINOMA 17 0.0019
408 BODY HEIGHT DECREASED 20 0.0019
409 HUMERUS FRACTURE 9 0.0019
410 BLOOD PRESSURE INADEQUATELY CONTROLLED 11 0.0018
411 RIB FRACTURE 37 0.0018
412 MYDRIASIS 23 0.0018
413 ACUTE PULMONARY OEDEMA 10 0.0018
414 FALL 592 0.0018
415 TOE AMPUTATION 9 0.0018
416 PAPILLOEDEMA 8 0.0018
417 FACIAL PARALYSIS 15 0.0018
418 CARDIAC FAILURE 141 0.0018
419 EAR DISORDER 8 0.0017
420 PERIPHERAL VASCULAR DISORDER 9 0.0017
421 CARDIAC FAILURE CONGESTIVE 140 0.0017
422 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
423 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
424 CARDIOMEGALY 21 0.0017
425 LUNG NEOPLASM MALIGNANT 70 0.0017
426 HYPERTENSION 360 0.0017
427 THERAPEUTIC RESPONSE DECREASED 103 0.0017
428 DIVERTICULUM 12 0.0017
429 CARDIAC DISORDER 157 0.0017
430 THERAPY NON-RESPONDER 75 0.0017
431 WRIST FRACTURE 20 0.0017
432 SYRINGE ISSUE 29 0.0017
433 PULMONARY THROMBOSIS 18 0.0016
434 BUNDLE BRANCH BLOCK LEFT 7 0.0016
435 TENSION 10 0.0016
436 ATRIAL FLUTTER 13 0.0016
437 ARRHYTHMIA 77 0.0016
438 CEREBRAL DISORDER 12 0.0016
439 DIABETIC NEUROPATHY 8 0.0016
440 LOWER LIMB FRACTURE 31 0.0016
441 PULMONARY OEDEMA 72 0.0016
442 SUDDEN DEATH 17 0.0016
443 NEPHROTIC SYNDROME 11 0.0016
444 POST PROCEDURAL INFECTION 13 0.0016
445 BLOOD PRESSURE INCREASED 244 0.0016
446 CLAVICLE FRACTURE 6 0.0016
447 TUBULOINTERSTITIAL NEPHRITIS 29 0.0015
448 PRODUCT USE ISSUE 289 0.0015
449 BRAIN NEOPLASM 14 0.0015
450 LOWER RESPIRATORY TRACT INFECTION 69 0.0015
451 PLEURISY 9 0.0015
452 SINUS HEADACHE 9 0.0015
453 TRICUSPID VALVE INCOMPETENCE 12 0.0015
454 CEREBRAL ATROPHY 6 0.0015
455 MITRAL VALVE INCOMPETENCE 17 0.0015
456 UMBILICAL HERNIA 7 0.0015
457 TERMINAL STATE 10 0.0015
458 RHINITIS 12 0.0015
459 BLOOD PRESSURE SYSTOLIC INCREASED 29 0.0015
460 LUNG INFECTION 23 0.0015
461 MENISCUS INJURY 9 0.0015
462 FACIAL PAIN 13 0.0015
463 HYPERCHOLESTEROLAEMIA 14 0.0014
464 SCIATICA 23 0.0014
465 LYMPHOMA 22 0.0014
466 NEOPLASM MALIGNANT 95 0.0014
467 CONCUSSION 11 0.0014
468 CARDIAC FAILURE CHRONIC 6 0.0014
469 DYSPHONIA 82 0.0014
470 EMPHYSEMA 14 0.0014
471 GLYCOSYLATED HAEMOGLOBIN INCREASED 35 0.0014
472 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
473 DERMATITIS BULLOUS 10 0.0014
474 CORONARY ARTERIAL STENT INSERTION 7 0.0014
475 DYSLIPIDAEMIA 7 0.0014
476 CYST 17 0.0014
477 MALAISE 591 0.0013
478 POLYURIA 11 0.0013
479 CARDIAC PACEMAKER INSERTION 8 0.0013
480 POLYARTHRITIS 7 0.0013
481 JOINT DISLOCATION 14 0.0013
482 OPTIC NEURITIS 12 0.0013
483 CORONARY ARTERY OCCLUSION 18 0.0013
484 THROMBOSIS 105 0.0013
485 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 68 0.0013
486 UROSEPSIS 12 0.0013
487 SKIN CANCER 28 0.0013
488 PHARYNGITIS 16 0.0013
489 MOTOR DYSFUNCTION 13 0.0013
490 DEAFNESS UNILATERAL 7 0.0013
491 SPINAL OSTEOARTHRITIS 11 0.0013
492 INFLAMMATION 64 0.0012
493 HAEMATOMA 32 0.0012
494 APHASIA 37 0.0012
495 RENAL DISORDER 57 0.0012
496 PULMONARY EMBOLISM 116 0.0012
497 BASAL CELL CARCINOMA 19 0.0012
498 MULTI-ORGAN FAILURE 21 0.0012
499 CARDIAC ARREST 100 0.0012
500 STRESS CARDIOMYOPATHY 7 0.0012
501 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
502 NEPHROPATHY 11 0.0012
503 PANCREATIC CARCINOMA 34 0.0012
504 RHINORRHOEA 76 0.0012
505 HEAD INJURY 37 0.0012
506 THYROID DISORDER 18 0.0012
507 IMPAIRED DRIVING ABILITY 13 0.0011
508 BLOOD UREA INCREASED 19 0.0011
509 NEOPLASM 13 0.0011
510 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
511 DYSARTHRIA 42 0.0011
512 DERMATITIS ALLERGIC 14 0.0011
513 BLOOD PRESSURE ABNORMAL 22 0.0011
514 PULMONARY HYPERTENSION 23 0.0011
515 HERPES ZOSTER 63 0.0011
516 BRONCHITIS 81 0.0011
517 ACUTE RESPIRATORY FAILURE 21 0.0011
518 HAEMOPTYSIS 30 0.0011
519 PULMONARY CONGESTION 14 0.0011
520 PEMPHIGOID 8 0.0011
521 CARDIAC OPERATION 9 0.0010
522 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
523 PNEUMONIA 338 0.0010
524 RENAL FAILURE 137 0.0010
525 LIMB INJURY 28 0.0010
526 STAPHYLOCOCCAL INFECTION 34 0.0010
527 GASTROENTERITIS 15 0.0010
528 ABNORMAL LOSS OF WEIGHT 7 0.0010
529 GENERAL PHYSICAL HEALTH DETERIORATION 118 0.0010
530 PNEUMOTHORAX 16 0.0010
531 CHOLECYSTITIS 12 0.0010
532 HALLUCINATION, AUDITORY 16 0.0010
533 ROAD TRAFFIC ACCIDENT 42 0.0010
534 COUGH 281 0.0010
535 PNEUMONIA ASPIRATION 25 0.0010
536 PROTEINURIA 19 0.0010
537 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
538 OSTEOMYELITIS 18 0.0010
539 SPEECH DISORDER 52 0.0010
540 MYASTHENIA GRAVIS 8 0.0010
541 FRUSTRATION TOLERANCE DECREASED 8 0.0010
542 INCORRECT PRODUCT STORAGE 13 0.0010
543 DEVICE ISSUE 88 0.0010
544 TYPE 2 DIABETES MELLITUS 33 0.0010
545 NERVE COMPRESSION 9 0.0010
546 PANIC REACTION 7 0.0010
547 URINARY TRACT INFECTION 165 0.0010
548 METASTASES TO LIVER 17 0.0010
549 BLOOD PRESSURE FLUCTUATION 23 0.0010
550 LACERATION 9 0.0010
551 POST PROCEDURAL COMPLICATION 18 0.0009
552 JOINT INJURY 20 0.0009
553 VERTIGO 57 0.0009
554 PSEUDOMONAS INFECTION 8 0.0009
555 ATELECTASIS 9 0.0009
556 PYELONEPHRITIS 8 0.0009
557 PRODUCTIVE COUGH 44 0.0009
558 HYPERLIPIDAEMIA 11 0.0009
559 DRUG INEFFECTIVE 1213 0.0009
560 BLOOD GLUCOSE FLUCTUATION 10 0.0009
561 BLADDER DISORDER 9 0.0009
562 HYPOAESTHESIA 135 0.0009
563 BLOOD CHOLESTEROL INCREASED 42 0.0009
564 VENTRICULAR FIBRILLATION 10 0.0009
565 SYNCOPE 90 0.0009
566 FOOT FRACTURE 17 0.0009
567 THERAPEUTIC PRODUCT EFFECT DECREASED 40 0.0009
568 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
569 BRONCHIECTASIS 6 0.0009
570 COLITIS ISCHAEMIC 6 0.0009
571 INFLUENZA 99 0.0009
572 CARDIOMYOPATHY 13 0.0009
573 LUNG DISORDER 43 0.0009
574 DEEP VEIN THROMBOSIS 57 0.0009
575 BLOOD DISORDER 7 0.0009
576 SENSORY DISTURBANCE 14 0.0009
577 TEMPERATURE INTOLERANCE 9 0.0009
578 UTERINE CANCER 7 0.0009
579 SENSORY LOSS 7 0.0009
580 METASTASES TO LUNG 10 0.0009
581 BLOOD POTASSIUM INCREASED 14 0.0009
582 ROTATOR CUFF SYNDROME 11 0.0009
583 APPENDICITIS 8 0.0009
584 ILL-DEFINED DISORDER 52 0.0009
585 SKIN ULCER 22 0.0009
586 OEDEMA 46 0.0008
587 CYSTITIS 27 0.0008
588 SEASONAL ALLERGY 12 0.0008
589 HEAD DISCOMFORT 15 0.0008
590 SPINAL COMPRESSION FRACTURE 7 0.0008
591 BREAST CANCER METASTATIC 9 0.0008
592 BEDRIDDEN 11 0.0008
593 PULMONARY FIBROSIS 16 0.0008
594 GASTRIC CANCER 21 0.0008
595 WOUND INFECTION 9 0.0008
596 MALIGNANT MELANOMA 11 0.0008
597 DISCOMFORT 50 0.0008
598 FEAR 22 0.0008
599 TOOTH FRACTURE 9 0.0008
600 MUSCULOSKELETAL DISCOMFORT 14 0.0008
601 CONFUSIONAL STATE 131 0.0008
602 MUSCULAR WEAKNESS 92 0.0008
603 CONDITION AGGRAVATED 246 0.0008
604 LIGAMENT SPRAIN 8 0.0008
605 CARDIAC MURMUR 7 0.0008
606 LIMB DISCOMFORT 25 0.0008
607 GENERALISED OEDEMA 10 0.0008
608 LOCAL SWELLING 14 0.0008
609 OSTEOARTHRITIS 34 0.0008
610 SPINAL FRACTURE 16 0.0008
611 BALANCE DISORDER 69 0.0008
612 TOXIC SKIN ERUPTION 8 0.0008
613 PRODUCT ADMINISTRATION ERROR 16 0.0008
614 MUSCLE ATROPHY 10 0.0008
615 HEADACHE 493 0.0008
616 HYPOGLYCAEMIA 38 0.0008
617 EAR DISCOMFORT 8 0.0008
618 ATRIOVENTRICULAR BLOCK 6 0.0008
619 METASTASES TO CENTRAL NERVOUS SYSTEM 10 0.0008
620 DIALYSIS 11 0.0008
621 DRUG EFFECT INCOMPLETE 28 0.0008
622 NASOPHARYNGITIS 142 0.0008
623 CHOLELITHIASIS 25 0.0008
624 GASTRITIS 20 0.0008
625 IRON DEFICIENCY ANAEMIA 7 0.0008
626 BLOOD GLUCOSE ABNORMAL 14 0.0008
627 HAEMATOCRIT DECREASED 15 0.0008
628 BLOOD ALBUMIN DECREASED 6 0.0008
629 AMNESIA 49 0.0008
630 EPILEPSY 23 0.0008
631 HYPERSENSITIVITY 138 0.0007
632 FEMUR FRACTURE 23 0.0007
633 BACK DISORDER 12 0.0007
634 SLEEP APNOEA SYNDROME 14 0.0007
635 GOUT 13 0.0007
636 ANGIOEDEMA 32 0.0007
637 PLEURAL EFFUSION 44 0.0007
638 GASTROENTERITIS VIRAL 13 0.0007
639 NERVE INJURY 8 0.0007
640 CARDIO-RESPIRATORY ARREST 30 0.0007
641 MASS 10 0.0007
642 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
643 ANKLE FRACTURE 11 0.0007
644 HEART RATE IRREGULAR 16 0.0007
645 DISORIENTATION 28 0.0007
646 INFECTION 102 0.0007
647 LOSS OF CONSCIOUSNESS 90 0.0007
648 SCAB 8 0.0007
649 PRESYNCOPE 17 0.0007
650 PARALYSIS 10 0.0007
651 ULCER 11 0.0007
652 MYELODYSPLASTIC SYNDROME 10 0.0007
653 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 49 0.0007
654 ABASIA 17 0.0007
655 BLOOD URINE PRESENT 13 0.0007
656 HEART RATE DECREASED 24 0.0007
657 RENAL FAILURE ACUTE 29 0.0007
658 CHEST PAIN 125 0.0007
659 PRODUCT STORAGE ERROR 59 0.0007
660 METASTASES TO BONE 11 0.0007
661 INJECTION SITE DISCOMFORT 7 0.0007
662 RED BLOOD CELL COUNT DECREASED 19 0.0007
663 NEUROPATHY PERIPHERAL 63 0.0007
664 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
665 SINUS DISORDER 13 0.0007
666 RENAL IMPAIRMENT 55 0.0007
667 GAIT DISTURBANCE 125 0.0007
668 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 22 0.0007
669 NERVOUSNESS 34 0.0007
670 BACK INJURY 7 0.0006
671 DEPRESSED MOOD 34 0.0006
672 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
673 MEMORY IMPAIRMENT 87 0.0006
674 BREAST CANCER 59 0.0006
675 ORTHOSTATIC HYPOTENSION 11 0.0006
676 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
677 VIRAL INFECTION 21 0.0006
678 BLOOD GLUCOSE INCREASED 118 0.0006
679 INTESTINAL PERFORATION 7 0.0006
680 DIZZINESS POSTURAL 6 0.0006
681 PRODUCT QUALITY ISSUE 84 0.0006
682 HIATUS HERNIA 8 0.0006
683 PRODUCT AVAILABILITY ISSUE 14 0.0006
684 DRUG EFFECT DECREASED 33 0.0006
685 KIDNEY INFECTION 12 0.0006
686 NEPHROLITHIASIS 28 0.0006
687 DIZZINESS 304 0.0006
688 BODY TEMPERATURE DECREASED 6 0.0006
689 EXPIRED PRODUCT ADMINISTERED 20 0.0006
690 RESPIRATORY DISORDER 18 0.0006
691 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
692 SEPSIS 66 0.0006
693 MOVEMENT DISORDER 19 0.0006
694 MUSCULOSKELETAL PAIN 31 0.0006
695 SWELLING 55 0.0006
696 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
697 OSTEOPOROSIS 24 0.0006
698 PRODUCT USE IN UNAPPROVED INDICATION 144 0.0006
699 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
700 SNEEZING 13 0.0006
701 BURSITIS 7 0.0006
702 NERVOUS SYSTEM DISORDER 18 0.0006
703 RESPIRATORY TRACT INFECTION 15 0.0006
704 NEURALGIA 14 0.0006
705 MEDICATION ERROR 32 0.0006
706 CELLULITIS 29 0.0006
707 ASTHMA 65 0.0006
708 COORDINATION ABNORMAL 8 0.0006
709 CARPAL TUNNEL SYNDROME 8 0.0006
710 BLOOD TEST ABNORMAL 8 0.0006
711 SWELLING FACE 37 0.0006
712 TINNITUS 26 0.0006
713 ARTHRITIS 44 0.0006
714 CARDIOGENIC SHOCK 8 0.0006
715 PAIN 342 0.0006
716 HAEMATURIA 19 0.0006
717 DRUG ADMINISTRATION ERROR 17 0.0006
718 LEUKOCYTOSIS 10 0.0006
719 HAEMATEMESIS 14 0.0006
720 HYPOKINESIA 8 0.0006
721 ANAEMIA 105 0.0005
722 INJECTION SITE IRRITATION 7 0.0005
723 HYPERGLYCAEMIA 20 0.0005
724 COAGULOPATHY 9 0.0005
725 NODULE 7 0.0005
726 BACTERIAL INFECTION 10 0.0005
727 INJECTION SITE PAIN 164 0.0005
728 BLOOD SODIUM DECREASED 10 0.0005
729 BACK PAIN 123 0.0005
730 DEVICE DISLOCATION 23 0.0005
731 GASTRIC ULCER 10 0.0005
732 EAR INFECTION 14 0.0005
733 C-REACTIVE PROTEIN INCREASED 19 0.0005
734 MUSCULOSKELETAL CHEST PAIN 8 0.0005
735 LIVER FUNCTION TEST ABNORMAL 15 0.0005
736 COGNITIVE DISORDER 24 0.0005
737 PROSTATE CANCER 41 0.0005
738 SINUSITIS 52 0.0005
739 ATAXIA 6 0.0005
740 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
741 INTESTINAL OBSTRUCTION 19 0.0005
742 FEELING ABNORMAL 120 0.0005
743 BLOOD GLUCOSE DECREASED 24 0.0005
744 HAEMOGLOBIN DECREASED 51 0.0005
745 DEPRESSION 113 0.0005
746 CRYING 18 0.0005
747 EPISTAXIS 37 0.0005
748 BONE DISORDER 9 0.0005
749 ARTHROPATHY 27 0.0005
750 NECK PAIN 27 0.0005
751 HYPOXIA 17 0.0005
752 BLOOD PRESSURE DECREASED 32 0.0005
753 FLUID OVERLOAD 7 0.0005
754 DYSPNOEA 272 0.0005
755 SHOCK 11 0.0005
756 PALLOR 13 0.0005
757 DERMATITIS 10 0.0005
758 NASAL CONGESTION 28 0.0005
759 FRACTURE 9 0.0005
760 FLUID RETENTION 24 0.0005
761 PULMONARY MASS 7 0.0005
762 HAEMORRHAGE INTRACRANIAL 7 0.0005
763 WRONG TECHNIQUE IN DRUG USAGE PROCESS 17 0.0005
764 CONTUSION 45 0.0005
765 HERNIA 9 0.0005
766 UNRESPONSIVE TO STIMULI 12 0.0005
767 HYPOAESTHESIA ORAL 7 0.0005
768 EAR PAIN 9 0.0005
769 HYPONATRAEMIA 26 0.0005
770 MENTAL DISORDER 20 0.0005
771 COLD SWEAT 8 0.0005
772 ASTHENIA 170 0.0005
773 DRUG ERUPTION 8 0.0005
774 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
775 TOOTH DISORDER 10 0.0004
776 URINARY RETENTION 15 0.0004
777 PREGNANCY 9 0.0004
778 GALLBLADDER DISORDER 8 0.0004
779 WEIGHT DECREASED 125 0.0004
780 NEEDLE ISSUE 13 0.0004
781 BLISTER 25 0.0004
782 BLOOD CREATININE INCREASED 29 0.0004
783 PREMATURE DELIVERY 7 0.0004
784 OBESITY 7 0.0004
785 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 79 0.0004
786 GASTRIC DISORDER 15 0.0004
787 TOOTH LOSS 9 0.0004
788 PARAESTHESIA 68 0.0004
789 MOBILITY DECREASED 31 0.0004
790 CHEST DISCOMFORT 44 0.0004
791 OEDEMA PERIPHERAL 52 0.0004
792 RESPIRATORY FAILURE 31 0.0004
793 VENTRICULAR TACHYCARDIA 7 0.0004
794 ERYTHEMA 87 0.0004
795 INTENTIONAL PRODUCT MISUSE 37 0.0004
796 RETCHING 9 0.0004
797 BRONCHOSPASM 6 0.0004
798 PALPITATIONS 49 0.0004
799 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
800 BRADYCARDIA 22 0.0004
801 ANOSMIA 6 0.0004
802 MENTAL IMPAIRMENT 10 0.0004
803 MYALGIA 70 0.0004
804 DYSSTASIA 12 0.0004
805 HAEMORRHOIDS 8 0.0004
806 URTICARIA 68 0.0004
807 PNEUMONITIS 11 0.0004
808 ARTHRALGIA 167 0.0004
809 PANCREATITIS 21 0.0004
810 LYMPHADENOPATHY 14 0.0004
811 PRODUCT COMPLAINT 10 0.0004
812 WOUND 11 0.0004
813 PERICARDIAL EFFUSION 9 0.0004
814 OROPHARYNGEAL PAIN 36 0.0004
815 TOOTHACHE 7 0.0004
816 ANXIETY 110 0.0004
817 RASH GENERALISED 10 0.0004
818 EJECTION FRACTION DECREASED 6 0.0004
819 CONVULSION 22 0.0004
820 SWOLLEN TONGUE 12 0.0004
821 INFLUENZA LIKE ILLNESS 31 0.0004
822 PERIPHERAL SWELLING 58 0.0004
823 HYPOTHYROIDISM 12 0.0004
824 BLADDER CANCER 22 0.0004
825 ACUTE KIDNEY INJURY 57 0.0004
826 URINARY INCONTINENCE 11 0.0004
827 BURNING SENSATION 26 0.0004
828 PRURITUS GENERALISED 8 0.0004
829 MUSCULOSKELETAL DISORDER 7 0.0004
830 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
831 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
832 DIVERTICULITIS 10 0.0004
833 TACHYCARDIA 32 0.0004
834 ILLNESS 37 0.0004
835 BONE PAIN 21 0.0004
836 GASTROINTESTINAL DISORDER 32 0.0004
837 OXYGEN SATURATION DECREASED 20 0.0004
838 HEART RATE INCREASED 35 0.0004
839 DRUG INTERACTION 56 0.0004
840 NAUSEA 277 0.0003
841 LETHARGY 20 0.0003
842 MUSCLE TWITCHING 8 0.0003
843 FEEDING DISORDER 7 0.0003
844 HALLUCINATION 26 0.0003
845 ANAPHYLACTIC REACTION 19 0.0003
846 TREMOR 57 0.0003
847 MIGRAINE 32 0.0003
848 IMPAIRED HEALING 11 0.0003
849 HEPATIC CANCER 8 0.0003
850 INJURY 23 0.0003
851 AGITATION 24 0.0003
852 TREATMENT FAILURE 27 0.0003
853 SLEEP DISORDER 23 0.0003
854 PAIN IN EXTREMITY 96 0.0003
855 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
856 POOR QUALITY SLEEP 7 0.0003
857 HYPOKALAEMIA 15 0.0003
858 ABORTION SPONTANEOUS 13 0.0003
859 PROCEDURAL PAIN 9 0.0003
860 FEELING COLD 9 0.0003
861 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
862 RASH MACULO-PAPULAR 7 0.0003
863 HYPOTENSION 63 0.0003
864 POLLAKIURIA 13 0.0003
865 ABDOMINAL DISCOMFORT 52 0.0003
866 CHOKING 6 0.0003
867 DEHYDRATION 41 0.0003
868 ASCITES 9 0.0003
869 ABDOMINAL PAIN UPPER 63 0.0003
870 JOINT STIFFNESS 8 0.0003
871 UNEVALUABLE EVENT 23 0.0003
872 DISABILITY 6 0.0003
873 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
874 RENAL INJURY 9 0.0003
875 ABNORMAL BEHAVIOUR 12 0.0003
876 RESTLESSNESS 11 0.0003
877 PLATELET COUNT DECREASED 32 0.0003
878 DYSURIA 11 0.0003
879 MUSCULOSKELETAL STIFFNESS 26 0.0003
880 COMA 14 0.0003
881 DYSPNOEA EXERTIONAL 11 0.0003
882 DIABETIC KETOACIDOSIS 7 0.0003
883 RESPIRATORY ARREST 8 0.0003
884 RESPIRATORY DISTRESS 8 0.0003
885 THROAT IRRITATION 13 0.0003
886 PYREXIA 100 0.0003
887 DELIRIUM 10 0.0003
888 FIBROMYALGIA 7 0.0003
889 FATIGUE 220 0.0003
890 RECTAL HAEMORRHAGE 12 0.0003
891 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
892 VOMITING 130 0.0003
893 INJECTION SITE HAEMORRHAGE 22 0.0003
894 PANIC ATTACK 10 0.0003
895 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
896 SKIN EXFOLIATION 23 0.0003
897 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
898 ANAPHYLACTIC SHOCK 7 0.0003
899 LIVER DISORDER 12 0.0003
900 LIP SWELLING 9 0.0003
901 SEDATION 7 0.0003
902 SEIZURE 30 0.0003
903 DISTURBANCE IN ATTENTION 14 0.0003
904 THROMBOCYTOPENIA 29 0.0003
905 BLOOD BILIRUBIN INCREASED 7 0.0003
906 NEOPLASM PROGRESSION 9 0.0003
907 MENTAL STATUS CHANGES 7 0.0003
908 ECZEMA 13 0.0002
909 NIGHT SWEATS 8 0.0002
910 RASH 107 0.0002
911 HYPERSOMNIA 7 0.0002
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
913 SKIN DISORDER 8 0.0002
914 WHEEZING 14 0.0002
915 OESOPHAGEAL CARCINOMA 7 0.0002
916 PRURITUS 90 0.0002
917 HYPERHIDROSIS 30 0.0002
918 PREMATURE BABY 7 0.0002
919 HEPATIC FAILURE 7 0.0002
920 RENAL CANCER 11 0.0002
921 PLASMA CELL MYELOMA 9 0.0002
922 CHRONIC KIDNEY DISEASE 17 0.0002
923 SURGERY 13 0.0002
924 INSOMNIA 59 0.0002
925 ABDOMINAL PAIN 51 0.0002
926 CHILLS 25 0.0002
927 COVID-19 37 0.0002
928 DYSPHAGIA 20 0.0002
929 FUNGAL INFECTION 7 0.0002
930 GAIT INABILITY 7 0.0002
931 INCORRECT DOSE ADMINISTERED 47 0.0002
932 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
933 DECREASED APPETITE 47 0.0002
934 MUSCLE SPASMS 37 0.0002
935 BLOOD POTASSIUM DECREASED 6 0.0002
936 JOINT SWELLING 24 0.0002
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
938 PSORIATIC ARTHROPATHY 8 0.0002
939 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
940 DIARRHOEA 124 0.0002
941 UNDERDOSE 14 0.0002
942 PSORIASIS 25 0.0002
943 RASH ERYTHEMATOUS 9 0.0002
944 DRUG INTOLERANCE 18 0.0002
945 COLITIS 7 0.0002
946 CONSTIPATION 40 0.0002
947 DYSPEPSIA 18 0.0002
948 IRRITABILITY 11 0.0002
949 COLITIS ULCERATIVE 8 0.0002
950 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
951 SKIN DISCOLOURATION 8 0.0002
952 ACCIDENTAL OVERDOSE 6 0.0002
953 ABDOMINAL DISTENSION 17 0.0002
954 DRUG DEPENDENCE 26 0.0002
955 SEPTIC SHOCK 7 0.0002
956 DRY MOUTH 13 0.0002
957 RHEUMATOID ARTHRITIS 18 0.0002
958 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
959 PRODUCT DOSE OMISSION ISSUE 44 0.0001
960 EMOTIONAL DISTRESS 18 0.0001
961 WEIGHT INCREASED 33 0.0001
962 DRUG DOSE OMISSION 24 0.0001
963 HAEMATOCHEZIA 8 0.0001
964 INTERSTITIAL LUNG DISEASE 7 0.0001
965 FLATULENCE 8 0.0001
966 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
967 SOMNOLENCE 27 0.0001
968 ALOPECIA 26 0.0001
969 INJECTION SITE REACTION 9 0.0001
970 OVERDOSE 28 0.0001
971 RASH PRURITIC 7 0.0001
972 EXPOSURE DURING PREGNANCY 8 0.0001
973 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
974 COLORECTAL CANCER 6 0.0001
975 PANCYTOPENIA 7 0.0001
976 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
977 AGGRESSION 6 0.0001
978 HOSPITALISATION 18 0.0001
979 FEELING HOT 7 0.0001
980 PRODUCT DOSE OMISSION 7 0.0001
981 FEBRILE NEUTROPENIA 7 0.0001
982 INJECTION SITE ERYTHEMA 13 0.0001
983 DEVICE MALFUNCTION 7 0.0001
984 SUICIDAL IDEATION 9 0.0001
985 ACNE 7 0.0001
986 FLUSHING 9 0.0001
987 COMPLETED SUICIDE 7 0.0001
988 ADVERSE EVENT 7 0.0001
989 ADVERSE DRUG REACTION 6 0.0001
990 NEUTROPENIA 8 0.0001
991 TOXICITY TO VARIOUS AGENTS 8 0.0000